Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleTechnology/Application

Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations

Camellia Zamiri, Danielle L. Leiske, Patricia Hughes, J. Paul Kirwan, Evelyn Der, Emily Cox, Rob Warburton, Monica Goss, Sarah Weiser, Janet Perez-Brown, Ganapathy Gopalrathnam, Jing Liu, Shyam B. Mehta, Shebeer Shereefa, Sebastian Specht, Sandra J. Aedo, Pierre Goldbach, Feng Jia, Barbara Kuehnle, Scott Page, Liesbeth Voeten, Li Yi and Chen Zhu
PDA Journal of Pharmaceutical Science and Technology July 2024, 78 (4) 475-500; DOI: https://doi.org/10.5731/pdajpst.2022.012806
Camellia Zamiri
1Pharmaceutical Development, Genentech (A Member of the Roche group), South San Francisco, CA 94080;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zamiri.camellia@gene.com danielle.leiske@abcellera.com
Danielle L. Leiske
2Product Quality Management, Seagen, Bothell, WA 98021;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zamiri.camellia@gene.com danielle.leiske@abcellera.com
Patricia Hughes
3Office of Pharmaceutical Manufacturing Assessment, Office of Product Quality, FDA/CDER, Silver Spring, MD 20993;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Paul Kirwan
4Global Regulatory Affairs and Strategy, CMC, Amgen, Thousand Oaks, CA 91320;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evelyn Der
5PTQP Analytical Sciences Chapter, Genentech (A Member of the Roche group), South San Francisco, CA 94080;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Cox
6BioPharmaceuticals Development, R&D, Dosage Form Design and Development, AstraZeneca, Gaithersburg, MD, 20878;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob Warburton
7Bioproduct Research & Development, Lilly Research Laboratories Eli Lilly and Company, Indianapolis, IN 46285;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Goss
8Drug Product Technologies, Amgen, Thousand Oaks, CA 91320;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Weiser
9BTx PharmSci, Pharmaceutical Research and Development, Pfizer, Andover, MA 01810;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Perez-Brown
10Microbiology Center of Excellence, BMS, New Brunswick, NJ 08903;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ganapathy Gopalrathnam
11Bioproduct Pharma Design, Lilly Research Laboratories Eli Lilly and Company, Indianapolis, IN 46285;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Liu
12Pharmaceutical Sciences, Seagen, Bothell, WA 98021;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shyam B. Mehta
13Drug Product Development and Operations, CMC Biologics, Teva Branded Pharmaceutical Products, West Chester, PA 19380;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shebeer Shereefa
14Regulatory Affairs CMC, AbbVie, North Chicago, IL 60064;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Specht
15Regulatory Affairs, CMC, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra J. Aedo
16BioTherapeutics Drug Product Development Janssen, Pharmaceutical Companies of Johnson & Johnson, Janssen Research and Development, Malvern, PA 19355;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Goldbach
17Pharmaceutical Development & Supplies, Pharma Technical Development, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Jia
18Biologics Drug Product, Biogen, Cambridge, MA 02142;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Kuehnle
19Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach /Riss, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Page
14Regulatory Affairs CMC, AbbVie, North Chicago, IL 60064;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liesbeth Voeten
20Analytical Development, Microbiology Center of Excellence Janssen, Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Yi
21Formulation Development, AbbVie, South San Francisco, CA 94080; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Zhu
22Biologics Drug Product Development and Manufacturing, Sanofi, Framingham, MA, 01701
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 78 (4)
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 4
July/August 2024
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
Camellia Zamiri, Danielle L. Leiske, Patricia Hughes, J. Paul Kirwan, Evelyn Der, Emily Cox, Rob Warburton, Monica Goss, Sarah Weiser, Janet Perez-Brown, Ganapathy Gopalrathnam, Jing Liu, Shyam B. Mehta, Shebeer Shereefa, Sebastian Specht, Sandra J. Aedo, Pierre Goldbach, Feng Jia, Barbara Kuehnle, Scott Page, Liesbeth Voeten, Li Yi, Chen Zhu
PDA Journal of Pharmaceutical Science and Technology Jul 2024, 78 (4) 475-500; DOI: 10.5731/pdajpst.2022.012806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
Camellia Zamiri, Danielle L. Leiske, Patricia Hughes, J. Paul Kirwan, Evelyn Der, Emily Cox, Rob Warburton, Monica Goss, Sarah Weiser, Janet Perez-Brown, Ganapathy Gopalrathnam, Jing Liu, Shyam B. Mehta, Shebeer Shereefa, Sebastian Specht, Sandra J. Aedo, Pierre Goldbach, Feng Jia, Barbara Kuehnle, Scott Page, Liesbeth Voeten, Li Yi, Chen Zhu
PDA Journal of Pharmaceutical Science and Technology Jul 2024, 78 (4) 475-500; DOI: 10.5731/pdajpst.2022.012806
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Global Regulatory Expectations
    • 3. Best Practices for Microbial Challenge In-Use Study Design and Execution
    • 4. Interpretation of Microbial Growth and Assignment of In-Use Hold Time
    • 5. Other Considerations
    • 6. USP <797> and Sterile Preparations in Pharmacies
    • 7. Conclusions
    • Conflict of Interest Statement
    • Acknowledgements
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Mechanical Container Closure Integrity Test: A Method for Cartridge Systems
  • Practical application of setting up an annual Contamination Control Strategy (CCS) assessment
  • A Container Closure Integrity Test Method for Vials Stored at Cryogenic Conditions Using Headspace Oxygen Analysis
Show more Technology/Application

Similar Articles

Keywords

  • Microbial challenge in-use studies
  • Microbial stability
  • In-use hold
  • In-use storage
  • Microbial growth
  • Microbial contamination
  • USP <51>
  • Microorganisms
  • Interpretation of microbial data

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire